Fidelity Investments
CADL icon

Fidelity Investments’s Candel Therapeutics CADL Stock Holding History

Fidelity Investments’s Portfolio CADL Stock Details CADL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$113M Buy
10,990,535
+3,518
+0% +$26.6K ﹤0.01% 1197
2026
Q1 		$53.8M Buy
10,987,017
+2,752,718
+33% +$15M ﹤0.01% 1403
2025
Q4 		$46.5M Buy
8,234,299
+914
+0% +$4.92K ﹤0.01% 1473
2025
Q3 		$42M Sell
8,233,385
-50
-0% -$289 ﹤0.01% 1500
2025
Q2 		$41.7M Buy
8,233,435
+1,148,119
+16% +$5.91M ﹤0.01% 1461
2025
Q1 		$40M Buy
7,085,316
+3,161,717
+81% +$25.8M ﹤0.01% 1433
2024
Q4 		$34.1M Buy
3,923,599
+3,917,026
+59,593% +$23.1M ﹤0.01% 1533
2024
Q3 		$45.6K Buy
+6,573
New +$40.8K ﹤0.01% 3818
2024
Q1 		– Sell
-298,384
Closed -$439K – 5393
2023
Q4 		$439K Sell
298,384
-140,674
-32% -$137K ﹤0.01% 2719
2023
Q3 		$408K Sell
439,058
-13,499
-3% -$15.6K ﹤0.01% 2678
2023
Q2 		$570K Sell
452,557
-160,600
-26% -$237K ﹤0.01% 2615
2023
Q1 		$840K Sell
613,157
-124,439
-17% -$243K ﹤0.01% 2558
2022
Q4 		$1.32M Sell
737,596
-161,803
-18% -$320K ﹤0.01% 2479
2022
Q3 		$2.82M Hold
899,399
– – ﹤0.01% 2338
2022
Q2 		$2.91M Sell
899,399
-1,072,827
-54% -$4.3M ﹤0.01% 2384
2022
Q1 		$10M Sell
1,972,226
-290,616
-13% -$1.44M ﹤0.01% 2118
2021
Q4 		$17.7M Sell
2,262,842
-237,158
-9% -$2.3M ﹤0.01% 1886
2021
Q3 		$27.1M Buy
+2,500,000
New +$20.7M ﹤0.01% 1689

Other funds holding CADL

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
HFF
Halter Ferguson Financial Carmel, Indiana $617M AUM 69.99% 1-Year Est. Return

Fidelity Investments's CADL Position: Q2 2026 in Review

Fidelity Investments increased its Candel Therapeutics (CADL) stake by 0.03% in Q2 2026, buying an estimated $26.6K and bringing the position to 10,990,535 shares worth $113M. The position accounts for ﹤0.01% of the portfolio, ranked #1197.

Fidelity Investments first reported a position in CADL in Q3 2021 and has held it in 18 quarters since. 138 funds tracked by Wall St. Rank hold CADL as of Q2 2026.

  • Fidelity Investments held 10,990,535 shares of Candel Therapeutics worth $113M as of Q2 2026.
  • Fidelity Investments bought 3,518 Candel Therapeutics shares in Q2 2026, an estimated $26.6K.
  • Candel Therapeutics made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #1197 holding.
  • Fidelity Investments first reported a position in Candel Therapeutics in Q3 2021 and has held it in 18 quarters since.
  • 138 funds tracked by Wall St. Rank held Candel Therapeutics as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.